Columbus GA 2型糖尿病临床试验
7项针对 2型糖尿病的研究正在 Columbus及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Centricity Research, Endocrine Consultants, Columbus
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- Centricity Research, Endocrine Consultants, Columbus
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Centricity Research Columbus Georgia Multispecialty, Columbus
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
招募中3 期
- Columbus Research Foundation, Columbus
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- IACT Health-Brookstone Centre Pkwy, Columbus
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
招募中2 期
- Centricity Research IRT - DBA IACT Health Columbus Piedmont, Columbus
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- Centricity Research Columbus Endocrinology, Columbus
其他城市的 2型糖尿病试验
- San Antonio, TX37 项研究
- Houston, TX31 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Chicago, IL19 项研究
- Miami, FL19 项研究
- Dallas, TX19 项研究
- Columbus, OH18 项研究
- Las Vegas, NV18 项研究
- Atlanta, GA17 项研究
- San Diego, CA17 项研究
- Los Angeles, CA16 项研究
Columbus的其他研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月1日。每项研究自行设定入选标准,由研究团队决定谁能参与。